Dr. Adam Cole is an associate in the San Francisco office of Wilson Sonsini Goodrich & Rosati.
Adam’s practice focuses on strategic intellectual property counseling in a variety of technical areas, including genomics, nucleic acid sequencing, molecular diagnostics, materials science, engineering, and other life science and biotechnological arts. He prosecutes patents both in the United States and internationally and conducts patent diligence, including the evaluation of patent portfolios and engaging in freedom-to-operate analyses.
Adam started with the firm as a scientific advisor in 2012, rose to senior patent agent, and transitioned to associate in 2019 after participating in the firm’s law-school work-study program for patent agents. Prior to joining the firm, Adam was a postdoctoral fellow at Stanford University, where he studied novel nanomaterials as contrast agents in the early detection of cancer through the use of multi-modality molecular imaging. Adam’s doctoral work at the University of Michigan College of Pharmacy focused on improving the delivery of magnetically targeted, therapeutic iron oxide nanoparticles to brain tumors.
Adam also teaches Patent Prosecution and the IP Practicum Clinic at UC Berkeley School of Law and is part of UC Berkeley Bakar Labs' Advisory Group.
Dr. Adam Cole is an associate in the San Francisco office of Wilson Sonsini Goodrich & Rosati.
Adam’s practice focuses on strategic intellectual property counseling in a variety of technical areas, including genomics, nucleic acid sequencing, molecular diagnostics, materials science, engineering, and other life science and biotechnological arts. He prosecutes patents both in the United States and internationally and conducts patent diligence, including the evaluation of patent portfolios and engaging in freedom-to-operate analyses.
Adam started with the firm as a scientific advisor in 2012, rose to senior patent agent, and transitioned to associate in 2019 after participating in the firm’s law-school work-study program for patent agents. Prior to joining the firm, Adam was a postdoctoral fellow at Stanford University, where he studied novel nanomaterials as contrast agents in the early detection of cancer through the use of multi-modality molecular imaging. Adam’s doctoral work at the University of Michigan College of Pharmacy focused on improving the delivery of magnetically targeted, therapeutic iron oxide nanoparticles to brain tumors.
Adam also teaches Patent Prosecution and the IP Practicum Clinic at UC Berkeley School of Law and is part of UC Berkeley Bakar Labs' Advisory Group.